Interesting philby. If I'm reading you right - So many thinking about, some even worrying about a takeover, but with Fuji and Cellularity positioned as major shareholders taking advantage of the very considerable number of CYP00x licensing opportunities, AND consequently driving the price up through licensing announcements and PR, Cynata could simply end up as a holding company with potential for the sp to move to $40, $50 and beyond. Competitive tensions ebb away and Fuji and Cellularity reap the benefits in two ways. Puts a different and far more exciting perspective on things for sure!
Interesting philby. If I'm reading you right - So many thinking...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 25.0¢ | $3.097K | 12.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29341 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 11015 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |